Home › NDC Lookup › Ingredients › Clotrimazole › 68462-0181-17
Clotrimazole 10 mg/g Cream, 15 g — NDC 68462-0181-17 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Clotrimazole 10 mg/g Cream, 15 g — NDC 68462-181-17 (Billing 68462-0181-17)

by Glenmark Pharmaceuticals Inc., USA · 15 g in 1 TUBE

This is a package of 15 g of Clotrimazole 10 mg/g Cream from Glenmark Pharmaceuticals Inc., USA, marketed since Aug 2010 and currently FDA-listed; retail pharmacies pay about $0.1989 per g (NADAC).

NDC 68462-0181-17
🏷️ FDA NDC (as labeled) 68462-181-17 billing pads the product segment with a zero
This package
Contains15 g Cost per g$0.1989 NADAC Per package$2.98 / 15 g Pack sizes4 compare ↓
Also priced by: Medicaid pays $0.4719/unit · Part D plans $0.3577/unit — full pricing hub ↓
Product page 68462-0181-35 Also comes in: 2 tubes 68462-181-48 30 g 68462-181-35 45 g 68462-181-47
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Clotrimazole (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0210-2026
Class II · Oct 31, 2025 — cGMP deviations (Blossom Pharmaceuticals) · FDA recall D-0211-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68462-181-17
Product NDC 68462-181
11-digit billing NDC 68462018117
NCPDP billing unit GM — per gram (weight)
RxCUI 309367
UNII G07GZ97H65
UPC 0368462181355
Application # ANDA090219
SPL Set ID f6898117-14f3-42d2-bc0e-d296add3ad70
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2010-08-04
Route TOPICAL
Dosage form CREAM
Substance CLOTRIMAZOLE
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90154020003705
GPI class Clotrimazole
GCN Seq No 007361
GCN 30370
HICL code 004137
Ingredient (HICL) Clotrimazole
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.08
AHFS class Azoles (Skin And Mucous Membrane)
FDB label name CLOTRIMAZOLE 1% TOPICAL CREAM
FDB brand name Clotrimazole
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 007361
  • GCN: 30370
  • GPI-14 (Medi-Span): 90154020003705
  • HICL (First Databank): 004137
  • AHFS class code: 84:04.08.08
  • RxCUI (RxNorm): 309367
Why two NDCs? The FDA registers this code as 68462-181-17 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68462-0181-17. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole and triazole derivatives, Imidazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name CLOTRIMAZOLE 1% TOPICAL CREAM Ingredient Clotrimazole
📖 What it is MedlinePlus · NLM

Topical clotrimazole is used to treat tinea corporis (ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Clotrimazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats fungal and yeast infections. Skin products treat athlete's foot, jock itch and ringworm. Vaginal creams treat vaginal yeast infections, and CLOTIC ear solution treats fun...
  • Wash and dry the area, then apply a thin layer twice a day, morning and night. Most labels say about 4 weeks for athlete's foot and ringworm and 2 weeks for jock itch. See a doctor...
  • The skin products listed here say they are not effective on the scalp or nails. If the infection is there, check with your doctor.
  • With CLOTIC ear solution, the reported ones were headache, pain where it goes in, ringing in the ear and tingling. Vaginal cream can briefly increase burning or itching. Call your...
📖 Read our full Clotrimazole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.199 $2.98 / 15 g
Medicaid paysCMS SDUD · 12 mo $0.4719 $7.08 / 15 g
Medicare drug plans payPart D · Q2 2026 $0.3577 $5.37 / 15 g
NADAC price history (per g) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.250 $0.192
▼ Down 16% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
68462-0181-17 You're viewing this 15 g in 1 TUBE $0.1989 / g $2.98 2010-08-04 — Active
68462-0181-35 68462-181-35 Main listing 30 g in 1 TUBE $0.1330 / g $3.99 2010-08-04 — Active
68462-0181-47 68462-181-47 45 g in 1 TUBE $0.1622 / g $7.30 2010-08-04 — Active
68462-0181-48 68462-181-48 2 TUBE in 1 CARTON / 45 g in 1 TUBE — — 2010-08-04 — Active

Per g, this pack runs about 50% above the cheapest pack (30 g, $0.1330 vs $0.1989 NADAC).

This pack accounts for about 23% of this product's recent Medicaid fills; most go to the 30 g pack. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package contains 15 g — 15 g in 1 tube.
How does this package differ from NDC 68462-0181-35?
Both are Clotrimazole 10 mg/g Cream — the drug itself is identical. This page's package is the 15 g one, while NDC 68462-0181-35 is the 30 g package. Per-g NADAC also differs: $0.1989 here vs $0.1330 for the 30 g pack.
What NDC number is used to bill for this package of Clotrimazole 10 mg/g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rugby Clotrimazole Antifungal Cream 1 g/100g 00536-1265-26 Rugby 1 tube $0.047 — Availability likely save 76%
Clotrimazole 1 g/100g 70000-0667-01 Cardinal 1 tube $0.063 — Availability likely save 68%
Clotrimazole 1% Athletes Foot 10 mg/g 70677-1002-01 STRATEGIC 1 tube $0.118 — Availability likely save 41%
TM-Clotrimazole 1 g/100g 83035-1062-03 Singular 1 tube $0.118 — Availability likely save 41%
Leader Athletes Foot Clotrimazole .01 g/g 70000-0542-01 LEADER 1 tube $0.122 — Discontinued save 39%
clotrimazole 1 g/100g 45802-0434-01 Padagis 1 tube $0.146 — Discontinued save 27%
Good Neighbor Pharmacy Clotrimazole 10 mg/g 24385-0205-01 AmerisourceBergen 1 tube $0.197 — Availability likely save 1%
Antifungal Cream 1 g/100g 68001-0475-45 BluePoint 1 tube $0.197 — Availability likely save 1%
Clotrimazole 10 mg/g 51672-1275-01 Sun 1 tube $0.199 AB Availability likely —
Clotrimazole 10 mg/gthis 68462-0181-17 Glenmark 15 g $0.199 AB Availability likely —
Clotrimazole 1 g/100g 51672-2002-01 Sun 1 tube $0.219 — Availability likely +10%
Rugby Antifungal Clotrimazole .01 g/g 00536-1272-11 Rugby 1 tube $0.228 — FDA listed +15%
Clotrimazole 10 mg/g 00168-0133-15 E. 15 g — AB Discontinued —
Clotrimazole 10 mg/g 00363-2105-01 Walgreen 1 tube — — FDA listed —
Ringworm 10 mg/g 00363-2107-01 Walgreen 1 tube — — FDA listed —
Walgreens Jock Itch 10 mg/g 00363-2109-01 Walgreen 1 tube — — FDA listed —
Lotrimin 10 mg/g 11523-0963-01 Bayer 1 tube — — FDA listed —
Lotrimin Antifungal 10 mg/g 11523-1125-01 Bayer 1 tube — — FDA listed —
Lotrimin 10 mg/g 11523-6549-01 Bayer 1 tube — — FDA listed —
Dr Sheffield Athletes Foot 10 mg/g 11527-0071-15 Sheffield 1 tube — — Discontinued —
Jock Itch 10 mg/g 11673-0062-15 TARGET 1 tube — — FDA listed —
Target Jock Itch 10 mg/g 11673-0893-14 Target 1 tube — — FDA listed —
UpandUp Clotrimazole 10 mg/g 11673-0910-02 Target 1 tube — — FDA listed —
Rite Aid antifungal ringworm 1 g/100g 11822-1110-01 Rite 1 tube — — FDA listed —
Clotrimazole Jock Itch 10 mg/g 11822-3423-01 Rite 1 tube — — FDA listed —
Signature Care Jock Itch 10 mg/g 21130-0210-01 Safeway 1 tube — — FDA listed —
Signature Care Athletes Foot 10 mg/g 21130-0870-14 Safeway 1 tube — — FDA listed —
Antifungal 10 mg/g 21922-0094-04 Encube 1 tube — — FDA listed —
terrasil Folliculitis Cream Maximum Strength 1 g/100g 24909-0064-50 Aidance 50 g — — FDA listed —
Kroger ATHLETES FOOT 10 mg/g 30142-0305-01 Kroger 1 tube — — FDA listed —
Kroger Jock Itch 10 mg/g 30142-0510-01 Kroger 1 tube — — FDA listed —
TopCare Antifungal 10 mg/g 36800-0495-69 Topco 1 tube — — FDA listed —
HEB Antifungal 10 mg/g 37808-0305-01 H 1 tube — — FDA listed —
meijer Athletes Foot 10 mg/g 41250-0305-02 Meijer 1 tube — — FDA listed —
Publix athletic foot 10 mg/g 41415-0056-75 Publix 1 tube — — FDA listed —
CAREONE Clotrimazole 10 mg/g 41520-0305-02 American 1 tube — — FDA listed —
Jock-Eze 10 mg/g 47832-0071-14 Bentlin 1 tube — — FDA listed —
Clotrimazole Athletes Foot 10 mg/g 49035-0812-01 Wal-Mart 1 tube — — FDA listed —
Jock Itch Clotrimazole Antifungal .01 g/g 49035-0837-05 WalMart 1 tube — — FDA listed —
clotrimazole 1 g/100g 50090-0562-00 A-S 1 tube — — FDA listed —
clotrimazole 1 g/100g 50090-1770-00 A-S 1 tube — — FDA listed —
Clotrimazole 1 g/100g 50090-4971-00 A-S 1 tube — — FDA listed —
Clotrimazole 1 g/100g 50090-6546-00 A-S 1 tube — — FDA listed —
Clotrimazole 10 mg/g 50090-7343-00 A-S 30 g — AB FDA listed —
Live Better Antifungal 10 mg/g 51143-0002-01 The 1 tube — — FDA listed —
CAREALL Clotrimazole 10 g/g 51824-0063-01 New 28 g — — FDA listed —
CAREALL Clotrimazole 10 mg/g 51824-0093-01 New 28 g — — FDA listed —
Fungicure Night Cream 10 mg/g 52389-0681-02 Kobayashi 1 tube — — FDA listed —
Clotrimazole 1% Athletes Foot 10 mg/g 52410-3024-04 Shield 28.3 g — — FDA listed —
Dermatin Antifungal .01 g/g 54473-0096-01 Melaleuca, 14 g — — FDA listed —
Fortinia 10 mg/g 54633-0314-80 The 80 g — — FDA listed —
Athletes Foot 10 mg/g 55315-0008-56 FRED'S, 1 tube — — FDA listed —
Family Wellness Clotrimazole 1 Anti Fungal Cream 10 mg/g 55319-0980-00 Family 1 tube — — FDA listed —
TheraPlus Plus 1 g/100g 55621-0003-01 Zhejiang 35 g — — FDA listed —
Cura Hongo Antifungal 1 g/100g 55758-0102-02 Pharmadel 1 tube — — Discontinued —
DG Health Athletes Foot 10 mg/g 55910-0118-00 Dolgencorp, 57 g — — FDA listed —
Publix Athletic Foot 10 mg/g 56062-0817-28 PUBLIX 1 tube — — FDA listed —
Micoclear 10 mg/g 57237-0350-15 Rising 1 tube — — FDA listed —
Mycozyl AC 10 mg/g 59088-0441-07 PureTek 85 g — — FDA listed —
Micotrin AC 10 mg/g 59088-0476-07 PureTek 85 g — — FDA listed —
Micomitin Antifungal 10 mg/g 59088-0642-07 PureTek 85 g — — FDA listed —
Clotrimazole 1% Athletes Foot 10 mg/g 59779-0305-01 CVS 1 tube — — FDA listed —
CVS Pharmacy ITCH RELIEF ANTIFUNGAL 10 mg/g 59779-0510-01 CVS 1 tube — — FDA listed —
CVS Antifungal Ringworm 1 g/100g 59779-0514-01 CVS 1 tube — — FDA listed —
Clotrimazole 1 g/100g 63187-0501-15 Proficient 1 tube — — FDA listed —
clotrimazole 1 g/100g 63187-0559-15 Proficient 1 tube — — FDA listed —
Antifungal 1% Clotrimazole Cream 1 g/100mL 64412-2010-01 Twincraft 1 tube — — FDA listed —
Family Care Antifungal 10 mg/g 65923-0052-28 United 1 tube — — FDA listed —
Major Clotrimazole 10 mg/g 66267-0980-15 NuCare 14.17 g — — FDA listed —
WinCo Foods Antifungal 10 mg/g 67091-0196-28 Winco 1 tube — — FDA listed —
Clotrimazole 10 mg/g 67296-2252-03 Redpharm 30 g — AB FDA listed —
Dynarex Antifungal 1 g/100g 67777-0231-11 Dynarex 6 tubes — — FDA listed —
Antifungal 1 g/100g 67777-0727-02 Dynarex 72 tubes — — FDA listed —
clotrimazole 1 g/100g 68071-3395-03 NuCare 30 g — — FDA listed —
clotrimazole 1 g/100g 68071-4225-05 NuCare 15 g — — FDA listed —
Clotrimazole 1% 10 mg/g 68747-3024-04 Dabur 28.3 g — — FDA listed —
Rugby Antifungal Clotrimazole .01 g/g 68788-8091-02 Preferred 1 tube — — FDA listed —
Clotrimazole 1 g/100g 68788-8216-03 Preferred 1 tube — — FDA listed —
Clotrimazole 1 g/100g 68788-8830-02 Preferred 1 tube — — FDA listed —
Rugby Clotrimazole Antifungal Cream 1 g/100g 68788-8901-02 Preferred 1 tube — — FDA listed —
PerfectHeal Antifungal 1 g/100g 69070-0303-01 Zhejiang 1 tube — — FDA listed —
Clotrimazole 1 g/100g 69396-0001-04 TRIFECTA 1 tube — — FDA listed —
Clotrimazole 1 g/100g 69396-0038-05 Trifecta 1 tube — — FDA listed —
Clotrimazole 1 g/100g 69396-0087-01 TRIFECTA 1 tube — — FDA listed —
FifthPulse clotrimazole cream 4oz 1 g/100g 69571-0019-01 Front 113.4 g — — FDA listed —
Clotrimazole 1% Athletes Foot 10 mg/g 69771-0032-23 GERI-GENTLE 113 g — — FDA listed —
Antifungal 1% Clotrimazole Cream 1 g/100mL 70856-3585-01 Defense 1 tube — — FDA listed —
Clotrimazole 10 mg/g 71205-0432-15 Proficient 1 tube — AB FDA listed —
Clotrimazole 1 g/100g 71205-0434-05 Proficient 1 tube — — FDA listed —
Rugby Antifungal Clotrimazole .01 g/g 71205-0738-15 Proficient 1 tube — — FDA listed —
Trimazole 1 g/100g 73352-0570-01 Trifluent 1 tube — — FDA listed —
Clotrimazole 1% Topical Antifungal Cream 1 g/100g 73715-0004-01 Mohnark 28 g — — Discontinued —
Clotrimazole 10 mg/g 80489-0002-01 OL 1 tube — — FDA listed —
Thera plus Antifungal Clotrimazole 10 mg/g 80684-0039-01 FOURSTAR 1 tube — — FDA listed —
Up and Up Athletes Foot 10 mg/g 82442-0022-28 Target 1 tube — — FDA listed —
SIMPLY VITAL Antifungal Cream 10 mg/mL 82460-0344-00 ALPHA 60 ml — — FDA listed —
SimplyVital Antifungal Clotrimazole 10 mg/mL 82460-0990-00 Alpha 1 jar — — FDA listed —
Clotrimazole 1% 1 g/100g 83324-0041-01 Chain 1 tube — — FDA listed —
PHARMBANNER Antifungal Soothing Cream 1 g/100g 83818-0017-01 Shenzhen 60 g — — FDA listed —
Megababe Fun Gal Stuff Antifungal 10 mg/g 84000-0908-00 Megababe 1 tube — — FDA listed —
Clotrimazole 10 mg/g 84387-0004-01 ALLIED 28.4 g — — FDA listed —
ElixirCurozole 1 g/100g 84546-0003-01 ELIXIR 1 tube — — FDA listed —
seebeellar clotrimazole 1% antifungal cream 1 g/100g 84558-0014-01 GUANGZHOU 100 g — — FDA listed —
Velloryn 1% Clotrimazole ANTIFUNGAL 1 g/100mL 84558-0017-01 GUANGZHOU 100 ml — — FDA listed —
Antifungal 1 g/100g 84722-3059-00 VIVE 1 g — — FDA listed —
DERMFREE Clotrimazole 1 g/100g 85248-0036-01 Jiangxi 60 g — — FDA listed —
SERYNTH Clotrimazole 1 g/100g 85248-0101-01 Jiangxi 30 g — — FDA listed —
Charmpoo TINEA VERSICOLOR TREATMENT ANTIFUNGAL 1 g/100g 85248-0143-01 Jiangxi 100 g — — FDA listed —
BODYKOO JOCK ITCH Cream 1 g/100g 85248-0228-01 Jiangxi 30 g — — FDA listed —
Tagrid Antifungal Ringworm Treatment 1% CLOTRIMAZOLE 1 g/100g 85384-0006-01 TAGRID 100 g — — FDA listed —
Tagrid Balanitis Relief 1 g/100g 85384-0018-01 TAGRID 30 g — — FDA listed —
Tagrid Antifungal Clotrimazole 1% 1 g/100g 85384-0019-01 TAGRID 100 g — — FDA listed —
Tagrid Antifungal Jock Itch Cream Non-Steroidal Clotrimazole 1% 1 g/100g 85384-0021-01 TAGRID 60 g — — FDA listed —
Tagrid Intertrigo Cream For Skin Fold Rash Clotrimazole 1% 1 g/100g 85384-0022-01 TAGRID 56.7 g — — FDA listed —
Tinea Versicolor Treatment Cream 10 mg/g 85398-0002-01 Beautivity 60 g — — FDA listed —
Hermon Clotrimazole antifungal treatment cream .57 g/57g 85398-0010-01 Beautivity 57 g — — FDA listed —
Terthon Clotrimazole 1% Antifungal Cream 1 g/100g 85849-0010-01 SOLALIA 30 g — — FDA listed —
Kerova ANTIFUNGAL 1 g/100g 85959-0002-01 Guangzhou 100 g — — FDA listed —
Kerova Clotrimazole 1 g/100g 85959-0003-01 Guangzhou 100 g — — FDA listed —
Clotrimazole 1% 10 mg/g 87228-1010-01 PHARMACY 28.4 g — — FDA listed —
Clotrimazole Cream 1 g/100g 87236-0014-14 Aldermed 1 tube — — FDA listed —
Athletes Foot Cream 1 g/100g 87739-0001-01 Shenzhen 28 g — — FDA listed —
Fungicure Liquid Gel 10 mg/g 52389-0733-09 Kobayashi 1 tube — — FDA listed —
Tagrid Antifungal Treament Clotrimazole 1% 10 mg/g 85384-0012-01 TAGRID 20 g — — FDA listed —
FifthPulse Clotrimazole Antifungal 10 mg/g 87525-0002-01 WeCare 1 tube — — FDA listed —
Tinea Versicolor Treatment Bar 10 mg/g 85398-0003-01 Beautivity 116 g — — FDA listed —
Alevazol 10 mg/g 29978-0918-60 Capital 1 tube — — FDA listed —
CAREALL Clotrimazole 10 mg/g 51824-0121-01 New 28 g — — FDA listed —
Clotrimazole 10 mg/g 73581-0451-01 YYBA 1 tube — — FDA listed —
Shailee Antifungal Cream 10 mg/g 87995-0001-01 Skinley 1 tube — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2010
On the market since
Aug 2010
📍
2026
Currently FDA-listed
16 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII LKG8494WBH
    Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII 461N1O614Y
    A synthetic oily liquid used as an emollient and solvent in medications. It helps dissolve active ingredients and improves how the medicine spreads or absorbs through the skin.
  • UNII CAL22UVI4M
    A synthetic emulsifier derived from sorbitol and fatty acids. It helps mix oil and water-based ingredients together and improves the texture and stability of the medicine.
  • UNII 6O92ICV9RU
    A waxy substance derived from sorbitol that helps mix oil and water together in medicines. It's used as an emulsifier to keep ingredients evenly blended and stable.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

6 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGlenmark Pharmaceuticals Inc., USA
Application holderGLENMARK PHARMACEUTICALS INC USA
FDA applicationANDA090219 (ANDA)
Labeler code68462
First marketedAug 2010
Product typeHuman Prescription Drug
Portfolio343 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⛔ Contraindications ⚠️ Warnings 🤒 Adverse Reactions 🔄 Drug Interactions 🤰 Pregnancy 🧒 Pediatric Use 🆘 Overdosage 🧬 Clinical Pharmacology 📦 How Supplied / Storage and Handling 📦 Storage and Handling 📋 Description 💬 Information for Patients ⚠️ Precautions 🍼 Nursing Mothers 📄 Carcinogenesis, Mutagenesis, Impairment of Fertility 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 65 words ▾

INDICATIONS AND USAGE Clotrimazole cream USP is indicated for the topical treatment of candidiasis due to Candida albicans and tinea versicolor due to Malassezia furfur. Clotrimazole is also available as a nonprescription item which is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes , Epidermophyton floccosum , and Microsporum canis.

⏱️ Dosage and Administration 60 words ▾

DOSAGE AND ADMINISTRATION Gently massage sufficient clotrimazole cream into the affected and surrounding skin areas twice a day, in the morning and evening. Clinical improvement, with relief of pruritis, usually occurs within the first week of treatment with clotrimazole cream. If the patient shows no clinical improvement after four weeks of treatment with clotrimazole cream, the diagnosis should be reviewed.

⛔ Contraindications 11 words ▾

CONTRAINDICATIONS Clotrimazole cream is contraindicated in individuals sensitive to its components.

⚠️ Warnings 8 words ▾

WARNINGS Clotrimazole cream is not for ophthalmic use.

🤒 Adverse Reactions 31 words ▾

ADVERSE REACTIONS The following adverse reactions have been reported in connection with the use of this product: erythema, stinging, blistering, peeling, edema, pruritis, urticaria, burning, and general irritation of the skin.

🔄 Drug Interactions 23 words ▾

Drug Interactions Synergism or antagonism between clotrimazole and nystatin, or amphotericin B, or flucytosine against strains of C. albicans has not been reported.

🤰 Pregnancy 199 words ▾

Usage in Pregnancy: Pregnancy Category B The disposition of 14 C-clotrimazole has been studied in humans and animals. Clotrimazole is very poorly absorbed following dermal application or intravaginal administration to humans. (See CLINICAL PHARMACOLOGY ) In clinical trials, use of vaginally applied clotrimazole in pregnant women in their second and third trimesters has not been associated with ill effects.

There are, however, no adequate and well-controlled studies in pregnant women during the first trimester of pregnancy. Studies in pregnant rats with intravaginal doses up to 100 mg/kg have revealed no evidence of harm to the fetus due to clotrimazole. High oral doses of clotrimazole in rats and mice ranging from 50 to 120 mg/kg resulted in embroyotoxicity (possible secondary to maternal toxicity), impairment of mating, decreased litter size and number of viable young and decreased pup survival to weaning.

However, clotrimazole was not teratogenic in mice, rabbits and rats at oral doses up to 200, 180 and 100 mg/kg, respectively. Oral absorption in the rat amounts to approximately 90% of the administered dose. Because animal reproduction studies are not always predictive of human response, this drug should be used only if clearly indicated during the first trimester of pregnancy.

🧒 Pediatric Use 21 words ▾

Pediatric Use Safety and effectiveness in children have been established for clotrimazole when used as indicated and in the recommended dosage.

🆘 Overdosage 21 words ▾

OVERDOSAGE Acute overdosage with topical application of clotrimazole is unlikely and would not be expected to lead to a life-threatening situation.

🧬 Clinical Pharmacology ~2 min read ▾

CLINICAL PHARMACOLOGY Clotrimazole is a broad-spectrum antifungal agent that is used for the treatment of dermal infections caused by various species of pathogenic dermatophytes, yeasts, and Malassezia furfur . The primary action of clotrimazole is against dividing and growing organisms. In vitro, clotrimazole exhibits fungistatic and fungicidal activity against isolates of Trichophyton rubrum, Trichophyton mentagrophytes , Epidermophyton floccosum, Microsporum canis and Candida species including Candida albicans .

In general, the in vitro activity of clotrimazole corresponds to that of tolnaftate and griseofulvin against the mycelia of dermatophytes ( Trichophyton, Microsporum, and Epidermophyton ), and to that of the polyenes (amphotericin B and nystatin) against budding fungi ( Candida ). Using an in vivo (mouse) and an in vitro (mouse kidney homogenate) testing system, clotrimazole and micronazole were equally effective in preventing the growth of the pseudomycelia and mycelia of Candida albicans . Strains of fungi having a natural resistance to clotrimazole are rare.

Only a single isolate of Candida guilliermondi has been reported to have primary resistance to clotrimazole. No single-step or multiple-step resistance to clotrimazole has developed during successive passages of Candida albicans and Trichophyton mentagrophytes . No appreciable change in sensitivity was detected after successive passage of isolates of C. albicans, C. krusei , or C. pseudotropicalis in liquid or solid media containing clotrimazole.

Also, resistance could not be developed in chemically induced mutant strains of polyene-resistant isolates of C. albicans . Slight, reversible resistance was noted in three isolates of C. albicans tested by one investigator. There is a single report that records the clinical emergence of C. albicans strain with considerable resistance to flucytosine and micronazole, and with cross-resistance to clotrimazole, the strain remained sensitive to nystatin and amphotericin B.

In studies of the mechanism of action, the minimum fungicide concentration of clotrimazole caused leakage of intracellular phosphorus compounds into the ambient medium with concomitant breakdown of cellular nucleic acids and accelerated potassium efflux. Both these events began rapidly and extensively after addition of the drug. Clotrimazole appears to be well absorbed in humans following oral administration and is eliminated mainly as inactive metabolites.

Following topical and vaginal administration, however, clotrimazole appears to be minimally absorbed. Six hours after the application of radioactive clotrimazole 1% cream and 1% solution onto intact and acutely inflamed skin, the concentration of clotrimazole varied from 100 mcg/cm 3 in the stratum corneum to 0.5 to 1 mcg/cm 3 in the stratum reticulare, and 0.1 mcg/cm 3 in the subcutis. No measurable amount of radioactivity (≤0.001 mcg/mL) was found in the serum within 48 hours after application under occlusive dressing of 0.5 mL of the solution or 0.8 g of the cream.

Only 0.5% or less of the applied radioactivity was excreted in the urine. Following intravaginal administration of 100 mg 14 C-clotrimazole vaginal tablets to nine adult females, an average peak serum level, corresponding to only 0.03 μg equivalent/mL of clotrimazole, was reached one to two days after application. After intravaginal administration of 5 g of 1% 14 C-clotrimazole vaginal cream containing 50 mg active drug, to five subjects (one with candidal colpitis), serum levels corresponding to approximately 0.01 μg equivalents/mL were reached between 8 and 24 hours after application.

📦 How Supplied / Storage and Handling 36 words ▾

HOW SUPPLIED Clotrimazole cream USP, 1% is supplied in 15, 30, 45 and (2 x 45) gram tubes. NDC 68462-181-17 (15 g) NDC 68462-181-35 (30 g) NDC 68462-181-47 (45 g) NDC 68462-181-48 (2 x 45 g)

📦 Storage and Handling 6 words ▾

Store between 2°C- 30°C (36°F -86°F).

📋 Description 102 words ▾

DESCRIPTION Clotrimazole cream USP, 1% contains clotrimazole USP, a synthetic antifungal agent having the chemical name {1-(o-Chloro-α, α-diphenylbenzyl)imidazole}; the molecular formula C 22 H 17 ClN 2 ; a molecular weight of 344.84; and the structural formula: Clotrimazole USP is an odorless, white crystalline substance. It is practically insoluble in water, sparingly soluble in ether and very soluble in polyethylene glycol 400, ethanol and chloroform. Each gram of clotrimazole cream USP contains 10 mg clotrimazole USP, dispersed in a vanishing cream base of sorbitan monostearate, polysorbate 60, cetyl esters wax, cetostearyl alcohol, octyldodecanol, purified water, and benzyl alcohol (1%) as preservative. structure

💬 Information for Patients 78 words ▾

Information for Patients: The patient should be advised to: 1. Use the medication for the full treatment time even though the symptoms may have improved. Notify the physician if there is no improvement after four weeks of treatment.

2. Inform the physician if the area of application shows signs of increased irritation (redness, itching, burning, blistering, swelling, oozing) indicative of possible sensitization. 3.

Avoid the use of occlusive wrappings or dressings. 4. Avoid sources of infection or reinfection.

⚠️ Precautions ~2 min read ▾

PRECAUTIONS General: If irritation or sensitivity develops with the use of clotrimazole cream, treatment should be discontinued and appropriate therapy instituted. Information for Patients: The patient should be advised to: 1. Use the medication for the full treatment time even though the symptoms may have improved.

Notify the physician if there is no improvement after four weeks of treatment. 2. Inform the physician if the area of application shows signs of increased irritation (redness, itching, burning, blistering, swelling, oozing) indicative of possible sensitization.

3. Avoid the use of occlusive wrappings or dressings. 4.

Avoid sources of infection or reinfection. Laboratory Tests If there is lack of response to clotrimazole cream, appropriate microbiological studies should be repeated to confirm the diagnosis and rule out other pathogens before instituting another course of antimycotic therapy. Drug Interactions Synergism or antagonism between clotrimazole and nystatin, or amphotericin B, or flucytosine against strains of C. albicans has not been reported.

Carcinogenesis, Mutagenesis, Impairment of Fertility An 18-month oral dosing study with clotrimazole in rats has not revealed any carcinogenic effect. In tests for mutagenesis, chromosomes of the spermatophores of Chinese hamsters which had been exposed to clotrimazole were examined for structural changes during the metaphase. Prior to testing, the hamsters had received five oral clotrimazole doses of 100 mg/kg body weight.

The results of this study showed that clotrimazole had no mutagenic effect. Usage in Pregnancy: Pregnancy Category B The disposition of 14 C-clotrimazole has been studied in humans and animals. Clotrimazole is very poorly absorbed following dermal application or intravaginal administration to humans.

(See CLINICAL PHARMACOLOGY ) In clinical trials, use of vaginally applied clotrimazole in pregnant women in their second and third trimesters has not been associated with ill effects. There are, however, no adequate and well-controlled studies in pregnant women during the first trimester of pregnancy. Studies in pregnant rats with intravaginal doses up to 100 mg/kg have revealed no evidence of harm to the fetus due to clotrimazole.

High oral doses of clotrimazole in rats and mice ranging from 50 to 120 mg/kg resulted in embroyotoxicity (possible secondary to maternal toxicity), impairment of mating, decreased litter size and number of viable young and decreased pup survival to weaning. However, clotrimazole was not teratogenic in mice, rabbits and rats at oral doses up to 200, 180 and 100 mg/kg, respectively. Oral absorption in the rat amounts to approximately 90% of the administered dose.

Because animal reproduction studies are not always predictive of human response, this drug should be used only if clearly indicated during the first trimester of pregnancy. Nursing Mothers It is not known whether this drug is excreted in human milk, caution should be exercised when clotrimazole is used by a nursing woman. Pediatric Use Safety and effectiveness in children have been established for clotrimazole when used as indicated and in the recommended dosage.

🍼 Nursing Mothers 26 words ▾

Nursing Mothers It is not known whether this drug is excreted in human milk, caution should be exercised when clotrimazole is used by a nursing woman.

📄 Carcinogenesis, Mutagenesis, Impairment of Fertility 73 words ▾

Carcinogenesis, Mutagenesis, Impairment of Fertility An 18-month oral dosing study with clotrimazole in rats has not revealed any carcinogenic effect. In tests for mutagenesis, chromosomes of the spermatophores of Chinese hamsters which had been exposed to clotrimazole were examined for structural changes during the metaphase. Prior to testing, the hamsters had received five oral clotrimazole doses of 100 mg/kg body weight.

The results of this study showed that clotrimazole had no mutagenic effect.

📄 Package Label / Principal Display Panel 18 words ▾

Principal Display Panel NDC 68462-181-35 Clotrimazole Cream USP, 1% For external use only. Not for ophthalmic use. carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
67.2K
Units reimbursed last 4 qtrs
1.4M
Gross reimbursed last 4 qtrs
$679.2K
Avg / prescription
$10.10
Avg / unit
$0.4719
Latest quarter Q1 2026
14.7KRx
Medicaid pays / g
$0.4719
gross reimbursed
vs
NADAC / g
$0.1989
acquisition cost
=
Spread
+$0.2730
+137% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
44% FFS 56% MCO
Fee-for-service · 29,922 Rx Managed care · 37,323 Rx
State Medicaid map
Alaska: no data reported AK Maine: 5,670 units · 406 per 100k residents ME Washington: 17,279 units · 221 per 100k residents WA Idaho: 1,230 units · 62.6 per 100k residents ID Montana: 1,725 units · 152 per 100k residents MT North Dakota: 1,404 units · 179 per 100k residents ND Minnesota: 9,088 units · 158 per 100k residents MN Wisconsin: 9,507 units · 161 per 100k residents WI Michigan: 14,490 units · 144 per 100k residents MI New York: 98,445 units · 503 per 100k residents NY Vermont: 2,895 units · 447 per 100k residents VT New Hampshire: 3,465 units · 247 per 100k residents NH Oregon: 14,699 units · 347 per 100k residents OR Nevada: 13,125 units · 411 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 4,482 units · 140 per 100k residents IA Illinois: 29,400 units · 234 per 100k residents IL Indiana: 37,695 units · 549 per 100k residents IN Ohio: 52,170 units · 443 per 100k residents OH Pennsylvania: 64,770 units · 500 per 100k residents PA New Jersey: 56,070 units · 604 per 100k residents NJ Massachusetts: 63,120 units · 902 per 100k residents MA California: 421,515 units · 1,082 per 100k residents CA Utah: 825 units · 24.1 per 100k residents UT Colorado: 4,965 units · 84.5 per 100k residents CO Nebraska: 3,195 units · 162 per 100k residents NE Missouri: no data reported MO Kentucky: 11,595 units · 256 per 100k residents KY West Virginia: 4,620 units · 261 per 100k residents WV Virginia: 41,265 units · 473 per 100k residents VA Maryland: 35,084 units · 568 per 100k residents MD Connecticut: 29,475 units · 815 per 100k residents CT Rhode Island: 15,645 units · 1,429 per 100k residents RI Arizona: 26,340 units · 354 per 100k residents AZ New Mexico: 3,870 units · 183 per 100k residents NM Kansas: 2,055 units · 69.9 per 100k residents KS Arkansas: 5,760 units · 188 per 100k residents AR Tennessee: 6,615 units · 92.8 per 100k residents TN North Carolina: 35,697 units · 329 per 100k residents NC South Carolina: 27,840 units · 518 per 100k residents SC Delaware: 2,970 units · 288 per 100k residents DE Oklahoma: 5,685 units · 140 per 100k residents OK Louisiana: 12,795 units · 280 per 100k residents LA Mississippi: 3,825 units · 130 per 100k residents MS Alabama: 8,983 units · 176 per 100k residents AL Georgia: 34,020 units · 308 per 100k residents GA D.C.: 9,965 units · 1,468 per 100k residents DC Hawaii: 12,045 units · 839 per 100k residents HI Texas: 97,005 units · 318 per 100k residents TX Florida: 74,850 units · 331 per 100k residents FL
Units reimbursed · per 100k residents
24.11,468
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 D.C. 1,468 /100k
2 Rhode Island 1,429 /100k
3 California 1,082 /100k
4 Massachusetts 902 /100k
5 Hawaii 839 /100k
6 Connecticut 815 /100k
7 New Jersey 604 /100k
8 Maryland 568 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
30 g68462-0181-35 169,163 Rx · $2,085,392
15 g this page68462-0181-17 67,245 Rx · $679,151
45 g68462-0181-47 50,696 Rx · $773,484
2 tubes68462-0181-48 No Medicaid data
Drug total (last 4 qtrs): 287,104 Rx · 10,612,833 units · $3,538,027 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Clotrimazole — the program that covers self-administered drugs. 13 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Clotrimazole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$6.43M
Claims incl. refills
276K
Beneficiaries
207.9K
Spend / beneficiary
$30.91
Spend / claim
$23.28
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 68462-0180-22 · Glenmark 68462-0184-49 · GLENMARK →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.